Paola Barboro Selected Research

Type II DNA Topoisomerases (Topoisomerase II)

1/2020

Etoposide and topoisomerase II inhibition for aggressive prostate cancer: Data from a translational study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Barboro Research Topics

Disease

23	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 06/2003
20	Neoplasms (Cancer) 01/2024 - 06/2003
4	Carcinogenesis 10/2014 - 03/2006
3	Carcinoma (Carcinomatosis) 01/2012 - 06/2009
2	Disease Progression 01/2023 - 08/2012
2	Circulating Neoplastic Cells 07/2020 - 09/2019
2	Colorectal Neoplasms (Colorectal Cancer) 04/2020 - 01/2020
1	Adenocarcinoma of Lung 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Lung Neoplasms (Lung Cancer) 12/2022
1	Breast Neoplasms (Breast Cancer) 09/2022
1	Inflammation (Inflammations) 01/2017
1	Adenocarcinoma 08/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 09/2022 - 06/2003
8	AndrogensIBA 01/2024 - 08/2012
7	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 09/2011
6	Heterogeneous-Nuclear Ribonucleoprotein KIBA 06/2018 - 06/2009
5	Nuclear Matrix-Associated ProteinsIBA 10/2015 - 06/2003
4	Aspartic Acid (Aspartate)FDA Link 09/2022 - 01/2020
4	Mixed Function Oxygenases (Monooxygenases)IBA 09/2022 - 01/2020
3	LigandsIBA 01/2023 - 01/2020
2	calix(4)pyrroleIBA 01/2023 - 12/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
2	Messenger RNA (mRNA)IBA 07/2020 - 01/2020
2	Notch ReceptorsIBA 04/2020 - 01/2020
2	Celecoxib (Celebrex)FDA Link 12/2019 - 01/2017
2	Hormones (Hormone)IBA 08/2012 - 06/2009
2	ChromatinIBA 01/2012 - 01/2009
2	Matrix Attachment Region Binding ProteinsIBA 01/2012 - 01/2009
1	CeramidesIBA 10/2023
1	LipidsIBA 10/2023
1	Transfer RNA (tRNA)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2023
1	AntigensIBA 01/2023
1	EnzymesIBA 01/2023
1	PyrrolesIBA 12/2022
1	Macrocyclic CompoundsIBA 12/2022
1	Extracellular Matrix ProteinsIBA 07/2020
1	PeriostinIBA 07/2020
1	Phenobarbital (Luminal)FDA Link 04/2020
1	Calcibiotic Root Canal SealerIBA 04/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Epidermal Growth Factor (EGF)IBA 01/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2020
1	etoposide phosphate (Etopophos)FDA Link 01/2020
1	Cetuximab (Erbitux)FDA Link 12/2019
1	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 06/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Hormone AntagonistsIBA 08/2012
1	CateninsIBA 08/2012
1	bicalutamide (Casodex)FDA LinkGeneric 09/2011
1	afimoxifene (hydroxytamoxifen)IBA 09/2011
1	imidazole mustard (BIC)IBA 09/2011
1	Docetaxel (Taxotere)FDA Link 06/2009
1	Dihydrotachysterol (AT 10)IBA 06/2009
1	Lamin Type B (Lamin B)IBA 03/2006
1	LaminsIBA 03/2006

Therapy/Procedure

12	Castration 01/2024 - 08/2012
9	Therapeutics 01/2024 - 06/2009
1	Lasers (Laser) 01/2012
1	Drug Therapy (Chemotherapy) 06/2009
1	Prostatectomy (Retropubic Prostatectomy) 06/2003